"Weekly Ketamine Infusions Show Initial, Repeated Depression Benefits" - Kevin Kunzmann
A new study shows that weekly ketamine infusions are associated with continued and maintained reductions in depressive symptoms among patients with treatment-resistant depression. A team of researchers conducted a randomized, double-blind crossover comparison of single ketamine infusion versus active placebo control midazolam. The assessment, held with 41 participants with treatment-resistant depression at single treatment center, observed patients receive six open-label ketamine infusions three times per week over two once patients had a relapse of depressive symptoms. Dennis Charney, MD, Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine at Mount Sinai and president of academic affairs for the Mount Sinai Health System said “No matter what treatment is being assessed, you have to follow those scientific approaches. For conditions that don’t have effective treatments available, there should be an open mind.”
— Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, President, Academic Affairs, Mount Sinai Health System